DDR1 Protein, Human (Biotinylated, HEK293, His-Avi)

The DDR1 protein is a tyrosine kinase and cell surface receptor for fibrillar collagen that tightly regulates cell attachment and affects extracellular matrix processes. Upon collagen binding, DDR1 initiates a signaling cascade involving SRC, activating MAP kinase. DDR1, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived DDR1 protein, expressed by HEK293, with C-Avi;C-hFc labeled tag.

For research use only. We do not sell to patients.
  • Species: Human
  • Source: HEK293
  • Storage:
    Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.
  • Biological Activity
  • Technical Parameters
  • Product Properties
  • Documentation
  • Help & FAQs

Biological Activity

Description

The DDR1 protein is a tyrosine kinase and cell surface receptor for fibrillar collagen that tightly regulates cell attachment and affects extracellular matrix processes. Upon collagen binding, DDR1 initiates a signaling cascade involving SRC, activating MAP kinase. DDR1, Human (Biotinylated, HEK293, His-Avi) is the recombinant human-derived DDR1 protein, expressed by HEK293, with C-Avi;C-hFc labeled tag.

Background

DDR1 protein serves as a tyrosine kinase and functions as a cell surface receptor for fibrillar collagen, playing a pivotal role in regulating cell attachment to the extracellular matrix and influencing processes such as extracellular matrix remodeling, cell migration, differentiation, survival, and proliferation. Upon collagen binding, DDR1 initiates a signaling cascade involving SRC and activates MAP kinases. This activation, in turn, leads to the up-regulation of matrix metalloproteinases MMP2, MMP7, and MMP9, facilitating extracellular matrix remodeling and promoting cell migration and wound healing. DDR1's significance extends to various physiological processes, including normal blastocyst implantation during pregnancy, mammary gland differentiation, lactation, and the maintenance of ear morphology and hearing. Additionally, DDR1 contributes to arterial wound healing by promoting smooth muscle cell migration and plays a role in tumor cell invasion, further underscoring its diverse functional repertoire. Notably, DDR1 phosphorylates PTPN11 as part of its regulatory activities.

Technical Parameters

  • Species Human
  • Source HEK293
  • Tag C-Avi;C-His
  • Accession
  • Gene ID
  • Molecular Construction
    • N-term
    • DDR1 (D21-A417)
      Accession # Q08345-1
    • His-Avi
    • C-term
  • Protein Length

    Extracellular Domain

  • Conjugation

    Biotin

  • Synonyms

    DDR1; HGK2; Prev. EDDR1; Neurotrophic Tyrosine Kinase, Receptor, Type 4; Prev. NTRK4; Discoidin Domain Receptor Family, Member 1; Prev. PTK3A; Epithelial Discoidin Domain Receptor 1; Prev. CAK; PTK3A Protein Tyrosine Kinase 3A; Prev. NEP; Receptor Protein-Tyrosine Kinase; RTK6; Neuroepithelial Tyrosine Kinase; Epithelial Discoidin Domain-Containing Receptor 1; Discoidin Domain Receptor DDR1e; CD167 Antigen-Like Family Member A; Discoidin Domain Receptor DDR1d; Tyrosine Kinase DDR; Protein-Tyrosine Kinase 3A; CD167; CD167a Antigen; Discoidin Receptor Tyrosine Kinase; MCK-10; Protein-Tyrosine Kinase RTK-6; MCK10; Mammary Carcinoma Kinase 10; TRK E; Tyrosine-Protein Kinase CAK; PTK3; Cell Adhesion Kinase; DDR; Discoidin Domain Receptor Tyrosine Kinase 1; TRKE

  • AA Sequence

    DMKGHFDPAKCRYALGMQDRTIPDSDISASSSWSDSTAARHSRLESSDGDGAWCPAGSVFPKEEEYLQVDLQRLHLVALVGTQGRHAGGLGKEFSRSYRLRYSRDGRRWMGWKDRWGQEVISGNEDPEGVVLKDLGPPMVARLVRFYPRADRVMSVCLRVELYGCLWRDGLLSYTAPVGQTMYLSEAVYLNDSTYDGHTVGGLQYGGLGQLADGVVGLDDFRKSQELRVWPGYDYVGWSNHSFSSGYVEMEFEFDRLRAFQAMQVHCNNMHTLGARLPGGVECRFRRGPAMAWEGEPMRHNLGGNLGDPRARAVSVPLGGRVARFLQCRFLFAGPWLLFSEISFISDVVNNSSPALGGTFPPAPWWPPGPPPTNFSSLELEPRGQQPVAKAEGSPTA

  • Predicted Molecular Mass

    47.0 kDa.

  • Molecular Weight

    Approximately 60-75 kDa, based on Bis-Tris PAGEunder reducing conditions, due to the glycosylation.

  • Glycosylation

    Yes

  • Purity

    ≥ 95%, as determined by Bis-Tris PAGE.

Product Properties

Appearance

Lyophilized powder.

Endotoxin Level

< 1 EU/μg, determined by LAL method.

Reconstitution

It is not recommended to reconstitute to a concentration less than 100 μg/mL in ddH2O. For long term storage it is recommended to add a carrier protein (0.1% BSA, 5% HSA, 10% FBS or 5% Trehalose).

Storage & Stability

Stored at -20°C for 2 years from date of receipt. After reconstitution, it is stable at 4°C for 1 week or -20°C for longer (with carrier protein). It is recommended to freeze aliquots at -20°C or -80°C for extended storage.

Shipping

Room temperature in continental US; may vary elsewhere.

Calculators

Reconstitution Calculator

Volume (to add to vial) = Mass (in vial) ÷ Desired Reconstitution Concentration

Volume (to add to vial) Volume (to add to vial)
=
Mass (in vial) Mass (in vial)
÷
Desired Reconstitution Concentration Desired Reconstitution Concentration
Dilution Calculator

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

Concentration (start) Concentration (start)
×
Volume (start) Volume (start)
=
Concentration (final) Concentration (final)
×
Volume (final) Volume (final)
The Specific Activity Calculator Equation
  • Specific Activity (Unit/mg)
  • Biological Activity (ED50)

Specific Activity (Unit/mg) = 106 ÷ Biological Activity (ED50)

Specific Activity (Unit/mg) Specific Activity (Unit/mg)
Unit/mg
= 106 ÷
Biological Activity (ED50) Biological Activity (ED50)
106 ÷
ng/mL
MOQ
Minimum order quantity
100 mg

Get Quote In-stock

Other size
Get Quote
Please select quantity
Amount: USD 0.00